CVM: Bathi resik saben saham (EPS TTM) CEL-SCI Corporation
CEL-SCI Corporation revenues are based on finding a capital balance during the period of drug clinical trials. The TTM net income per share illustrates the quality of the business, where the metric value is -2.60. Growth prospects rely on the implementation of biologics in surgery and compliance with environmental standards for chemical waste processing in research centers.
cel-sci.com - rincian analitis lan metrik utama (CVM)
- kuotasi saiki lan rata-rata prakiraan nilai:
- informasi kapitalisasi pasar:
- rincian valuasi buku bisnis:
- rincian utang lan likuiditas:
Utang marang Ekuitas CEL-SCI Corporation|CVM - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas cel-sci.com|CVM - Tanggungan utang total perusahaan|Rasio utang marang kapitalisasi buku CEL-SCI|CVM - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan CEL-SCI|Rasio cepet cel-sci.com
- indikator pendapatan resik lan kelipatan nilai:
CVM - Asil keuangan resik|Bathi mangsa ngarep CEL-SCI Corporation|CVM - Nilai perusahaan marang bathi resik|Pangali Forward P/E CEL-SCI|CVM - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CEL-SCI Corporation|CVM - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan CEL-SCI|CVM - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan cel-sci.com|CVM - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep CEL-SCI Corporation
- rincian pendapatan lan dodolan:
Analisis komprehensif perusahaan:CVM - CEL-SCI Corporation
CEL-SCI Corporation (CVM) operates in an intensive R&D mode without commercial sales, leading to a systemic reduction of capital. Fundamental net income per share TTM aggregates annual results, distributing the final financial outcome across the total volume of issuance. Negative dynamics for this metric reflect the burn rate of resources dedicated to immunotherapy development. This chart allows for an assessment of the business's loss rates. Investors perceive this trend as a risk of liquidity depletion.
Pesaing CEL-SCI Corporation
ONC - Bathi saben saham sajrone rolas wulan pungkasan|HALO - Bathi resik saben saham (EPS TTM)|RevMed (RVMD) - Bathi saben saham sajrone rolas wulan pungkasan|Ascentage - Bathi saben saham sajroning taun lumaku|CGON (CG Oncology Inc) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan UroGen Pharma URGN|Bathi resik saben saham (EPS TTM) BCAX|PSNL: Bathi saben siji saham sajrone 12 wulan pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Erasca Corp ERAS|Delcath Corp (DCTH) - Bathi resik saben siji saham sajrone rolas wulan pungkasan|YMAB - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajroning taun lumaku AURA (Aura Biosciences, Inc.)|CADL: Bathi resik saben saham (EPS TTM)|Accuray Inc (ARAY) - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone rolas wulan pungkasan SELLAS Life Sciences Group|Bathi resik saben saham (EPS TTM) Actuate Therapeutics, Inc.|Bathi saben saham sajrone rolas wulan pungkasan citiusonc.com (CTOR)|Bathi resik saben saham (EPS TTM) TuHURA (HURA)|Bathi resik saben saham (EPS TTM) TARA (protaratx.com)|Bathi saben saham sajroning taun lumaku FATE|WHWK - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajroning taun lumaku TCRX (tscan.com)|Champions Oncology (CSBR) - Bathi saben saham sajrone rolas wulan pungkasan|XBiotech Inc - Bathi saben saham sajroning taun lumaku|OSTX (OS Therapies Inc.) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone 12 wulan pungkasan Radiopharm Theranostics (RADX)|Bathi resik saben saham sajrone 12 wulan pungkasan ARTV (Artiva Biotherapeutics, Inc.)|ANL - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Veru Inc. VERU|Bathi saben saham sajroning taun lumaku TPST|XLO: Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi resik saben saham sajrone patang kuartal pungkasan Renovaro RENB|MURA (muraloncology.com) - Bathi resik saben saham sajrone 12 wulan pungkasan|Kairos Pharma Inc - Bathi saben saham sajroning taun lumaku|Bathi resik saben saham sajrone 12 wulan pungkasan OKUR|Bathi resik saben siji saham sajrone rolas wulan pungkasan CytoMed Therapeutics Limited GDTC|Bathi resik saben saham (EPS TTM) CRIS|Bathi resik saben saham (EPS TTM) Apollomics Inc. (APLM)|Bathi resik saben saham (EPS TTM) THAR (Tharimmune Corp)|Bathi resik saben saham sajrone patang kuartal pungkasan Advanced Biomed Inc (ADVB)|Genprex Inc - Bathi resik saben saham (EPS TTM)|CLDI - Bathi resik saben saham (EPS TTM)|Sunshine Biopharma Inc. (SBFM) - Bathi saben saham sajrone rolas wulan pungkasan|XBIO - Bathi resik saben saham sajrone patang kuartal pungkasan|SLRX (Salarius Pharma) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham (EPS TTM) Kitov Pharma|Bathi resik saben saham sajrone 12 wulan pungkasan AONC (American Oncology Network)|BGNE - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Bathi resik saben saham (EPS TTM) CKPT (Checkpoint Therapeutics Inc.)|Elevation Oncology, Inc. - Bathi saben saham sajrone rolas wulan pungkasan|ICAD - Bathi saben saham sajrone rolas wulan pungkasan|IKNA - Bathi resik saben saham (EPS TTM)|Notable Labs (NTBL) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajrone 12 wulan pungkasan VIRX|MOR (MorphoSys Corporation) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan NAYA Biosciences Inc NAYA|Bathi saben saham sajrone rolas wulan pungkasan Ascentage Pharma (AAPGV)
